Depression and Cardiovascular Health Care Costs Among Women With Suspected Myocardial Ischemia. Prospective Results From the WISE (Women's Ischemia Syndrome Evaluation) Study

Journal of the American College of Cardiology

Volumn 53, Issue 2, 2009, Pages 176-183

  Rutledge, Thomas ^a,b   Vaccarino, Viola ^c   Johnson, B Delia ^d   Bittner, Vera ^f   Olson, Marian B ^d   Linke, Sarah E ^b   Cornell, Carol E ^g   Eteiba, Wafia ^d   Sheps, David S ^h,i   Francis, Jennifer ^j   Krantz, David S ^j   Bairey Merz, C Noel ^k   Parashar, Susmita ^c   Handberg, Eileen ^h   Vido, Diane A ^e   Shaw, Leslee J ^g  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e ALLEGHENY GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ North Florida/South Georgia VA Healthcare System   (United States)

^j UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^k CEDARS SINAI MEDICAL CENTER   (United States)

more..

Author keywords

cardiovascular disease; depression; health care costs; prospective; women

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANXIOLYTIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BECK DEPRESSION INVENTORY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST MINIMIZATION ANALYSIS; DEPRESSION; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEALTH CARE COST; HEALTH INSURANCE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PATIENT CARE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SOCIAL STATUS; WAIST HIP RATIO;

CORONARY ANGIOGRAPHY; DEPRESSIVE DISORDER; FEMALE; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; WOMEN'S HEALTH;

EID: 58149094581     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.09.032     Document Type: Article

References (42)

1. Evans D.L., Charney D.S., Lewis L., et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58 (2005) 175-189
2. Pincus H.A., and Pettit A.R. The societal costs of chronic major depression. J Clin Psychiatry 62 Suppl 6 (2001) 5-9
3. Whooley M.A. Depression and cardiovascular disease: healing the broken-hearted. JAMA 295 (2006) 2874-2881
4. Creed F., Morgan R., Fiddler M., Marshall S., Guthrie E., and House A. Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 43 (2002) 302-309
5. Simon G.E., Katon W.J., Lin E.H., et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 27 (2005) 344-351
6. Barth J., Schumacher M., and Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66 (2004) 802-813
7. Brunello N., Armitage R., Feinberg I., et al. Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology 42 (2000) 107-119
8. Garcia-Cebrian A., Gandhi P., Demyttenaere K., and Peveler R. The association of depression and painful physical symptoms-a review of the European literature. Eur Psychiatry 21 (2006) 379-388
9. Kop W.J., and Gottdiener J.S. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med 67 Suppl 1 (2005) S37-S41
10. Volkow N.D. The reality of comorbidity: depression and drug abuse. Biol Psychiatry 56 (2004) 714-717
11. Berto P., D'Ilario D., Ruffo P., Di Virgilio R., and Rizzo F. Depression: cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ 3 (2000) 3-10
12. Stewart W.F., Ricci J.A., Chee E., Hahn S.R., and Morganstein D. Cost of lost productive work time among US workers with depression. JAMA 289 (2003) 3135-3144
13. Burton W.N., Chen C.Y., Conti D.J., Schultz A.B., and Edington D.W. The association of antidepressant medication adherence with employee disability absences. Am J Manag Care 13 (2007) 105-112
14. Garis R.I., and Farmer K.C. Examining costs of chronic conditions in a Medicaid population. Manag Care 11 (2002) 43-50
15. Le T.K., Able S.L., and Lage M.J. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc 4 (2006) 18
16. Simon G.E., Katon W.J., Lin E.H., et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry 64 (2007) 65-72
17. Luppa M., Heinrich S., Angermeyer M.C., Konig H.H., and Riedel-Heller S.G. Cost-of-illness studies of depression: a systematic review. J Affect Disord 98 (2007) 29-43
18. Sullivan M., Simon G., Spertus J., and Russo J. Depression-related costs in heart failure care. Arch Intern Med 162 (2002) 1860-1866
19. Katon W.J., Lin E., Russo J., and Unutzer J. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry 60 (2003) 897-903
20. Cuijpers P., Smit F., Oostenbrink J., de Graaf R., Ten Have M., and Beekman A. Economic costs of minor depression: a population-based study. Acta Psychiatr Scand 115 (2007) 229-236
21. Mallik S., Spertus J.A., Reid K.J., et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med 166 (2006) 876-883
22. Bairey Merz C.N., Kelsey S.F., Pepine C.J., et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology, and feasibility report. J Am Coll Cardiol 33 (1999) 1453-1461
23. Sharaf B.L., Pepine C.J., Kerensky R.A., et al. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] study angiographic core laboratory). Am J Cardiol 87 (2001) 937-941
24. Mahoney E.M., Jurkovitz C.T., Chu H., et al. Cost and cost effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA 288 (2002) 1851-1858
25. Shaw L.J., Merz C.N., Pepine C.J., et al., Women's Ischemia Syndrome Evaluation (WISE) Investigators. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Circulation 114 (2006) 894-904
26. Johnson B.D., Shaw L.J., Buchthal S.D., et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 2993-2999
27. Shaw L.J., Lewis J.F., Hlatky M.A., et al. Women's Ischemia Syndrome Evaluation, current status and future research directions: report of the National Heart, Lung, and Blood Institute Workshop October 2-4, 2002: Gender-Related Risk Factors for Ischemic Heart Disease. Circulation 109 (2004) e56-e58
28. Mark D.B., and Hlatky M.A. Medical economics in the assessment of value in cardiovascular medicine, part I. Circulation 106 (2002) 516-520
29. Mark D.B., and Hlatky M.A. Medical economics in the assessment of value in cardiovascular medicine, part II. Circulation 106 (2002) 626-630
30. Shaw L.J., Heller G.V., Travin M.I., et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. J Nucl Cardiol 6 (1999) 559-569
31. Thomson Healthcare. PDR bookstore. http://www.pdrbookstore.com Accessed July 4, 2004.
32. U.S. Department of Labor, Bureau of Labor Statistics. Consumer Price Index home page. http://www.bls.gov/cpi/home.htm#data Accessed August 16, 2006.
33. Beck A.T. Depression Inventory (1978), Center for Cognitive Therapy, Philadelphia
34. Rozanski A., Blumenthal J.A., and Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99 (1999) 2192-2217
35. Hlatky M.A., Boineau R.E., Higginbotham M.B., et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 64 (1989) 651-654
36. Yusuf S., Hawken S., Ounpuu S., et al., INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
37. The Writing Group for the PEPI trial. Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions Trial. JAMA 273 (1995) 199-208 (erratum in JAMA 1995;274:1676)
38. Wang P.S., Patrick A., Avorn J., et al. The costs and benefits of enhanced depression care to employers. Arch Gen Psychiatry 63 (2006) 1345-1353
39. Von Korff M., Katon W., Bush T., et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med 60 (1998) 143-149
40. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55 (1998) 580-592
41. Unutzer J., Patrick D.L., Simon G., et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA 277 (1997) 1618-1623
42. Ziegelstein R.C., Kim S.Y., Kao D., et al. Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening?. Psychosom Med 67 (2005) 393-397